/KIDS
KIDS Stock - OrthoPediatrics Corp.
Healthcare|Medical - DevicesNASDAQ
$17.07-2.85%
$0.50 (-2.85%) • Dec 19
67
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.24
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.78
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+40.6%upside
Target: $24.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for KIDS
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$16.90 – $17.24
TARGET (TP)$24.00
STOP LOSS$15.70
RISK/REWARD1:5.1
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.06
52W High$27.60
52W Low$15.28
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $204.73M | $148.73M | $122.29M | $98.05M | $71.08M |
| Gross Profit | $148.60M | $111.25M | $90.66M | $73.40M | $55.03M |
| Gross Margin | 72.6% | 74.8% | 74.1% | 74.9% | 77.4% |
| Operating Income | $-29,521,000 | $-26,751,000 | $-25,399,000 | $-18,024,000 | $-26,755,000 |
| Net Income | $-37,822,000 | $-20,974,000 | $1.26M | $-16,260,000 | $-32,944,000 |
| Net Margin | -18.5% | -14.1% | 1.0% | -16.6% | -46.3% |
| EPS | $-1.64 | $-0.92 | $0.06 | $-0.84 | $-1.82 |
Company Overview
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
2
67%
Hold / Neutral
1
33%
Sell / Underperform
0%
Analyst Consensus🟡 Mixed
2 Bullish1 Neutral/Bearish
Price Targets
$31
Average Target
↑ 79.7% Upside
Now
$24
Low
$31
Average
$37
High
Based on 3 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 10th 2025 | Canaccord Genuity | Initiation | Buy | $24 |
| April 7th 2025 | Lake Street | Initiation | Buy | $37 |
| January 25th 2024 | Truist | Downgrade | Hold | $31← $39 |
Earnings History & Surprises
KIDSBeat Rate
61%
Last 18 quarters
Avg Surprise
+10.4%
EPS vs Estimate
Beats / Misses
11/4
3 met exactly
Latest EPS
$-0.24
Q4 2025
EPS Surprise History
Q1 24
+17.9%
$-0.23vs$-0.28
Q2 24
+28.6%
$-0.30vs$-0.42
Q3 24
+25.8%
$-0.23vs$-0.31
Q4 24
-50.0%
$-0.18vs$-0.12
Q1 25
+12.1%
$-0.29vs$-0.33
Q2 25
-50.0%
$-0.39vs$-0.26
Q3 25
+35.3%
$-0.11vs$-0.17
Q4 25
+7.7%
$-0.24vs$-0.26
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 5, 2026 | — | — | — | — |
Q1 2026 | Mar 3, 2026 | $-0.29 | — | — | — |
Q4 2025 | Oct 28, 2025 | $-0.26 | $-0.24 | +7.7% | ✓ BEAT |
Q3 2025 | Aug 5, 2025 | $-0.17 | $-0.11 | +35.3% | ✓ BEAT |
Q2 2025 | May 7, 2025 | $-0.26 | $-0.39 | -50.0% | ✗ MISS |
Q1 2025 | Mar 4, 2025 | $-0.33 | $-0.29 | +12.1% | ✓ BEAT |
Q4 2024 | Nov 6, 2024 | $-0.12 | $-0.18 | -50.0% | ✗ MISS |
Q3 2024 | Aug 5, 2024 | $-0.31 | $-0.23 | +25.8% | ✓ BEAT |
Q2 2024 | May 6, 2024 | $-0.42 | $-0.30 | +28.6% | ✓ BEAT |
Q1 2024 | Mar 6, 2024 | $-0.28 | $-0.23 | +17.9% | ✓ BEAT |
Q4 2023 | Nov 6, 2023 | $-0.20 | $-0.13 | +35.0% | ✓ BEAT |
Q3 2023 | Jul 31, 2023 | $-0.19 | $-0.19 | 0.0% | = MET |
Q2 2023 | May 1, 2023 | $-0.29 | $-0.29 | 0.0% | = MET |
Q1 2023 | Feb 28, 2023 | $-0.22 | $-0.32 | -45.5% | ✗ MISS |
Q4 2022 | Oct 31, 2022 | $-0.19 | $-0.05 | +73.7% | ✓ BEAT |
Q3 2022 | Aug 3, 2022 | $-0.15 | $-0.17 | -13.3% | ✗ MISS |
Q2 2022 | May 4, 2022 | $-0.30 | $-0.30 | 0.0% | = MET |
Q1 2022 | Mar 2, 2022 | $-0.30 | $-0.24 | +20.0% | ✓ BEAT |
Q4 2021 | Nov 3, 2021 | $-0.26 | $-0.15 | +42.3% | ✓ BEAT |
Q3 2021 | Aug 4, 2021 | $-0.21 | $-0.11 | +47.6% | ✓ BEAT |
Latest News
Canaccord Genuity Initiates Coverage On OrthoPediatrics with Buy Rating, Announces Price Target of $24
📈 PositiveBenzinga•Dec 10, 2025, 01:01 PM•Also:
OrthoPediatrics Expands Specialty Bracing Portfolio With Launch Of PediHip Rigid Brace And PediHip Modular Abduction System
📈 PositiveBenzinga•Nov 13, 2025, 12:15 PM
KIDS stock has given up its prior gain. OrthoPediatrics shares were trading higher following Q3 financial results.
📉 NegativeBenzinga•Oct 29, 2025, 07:07 PM
OrthoPediatrics shares are trading higher following Q3 financial results.
📈 PositiveBenzinga•Oct 29, 2025, 10:40 AM
Needham Maintains Buy on OrthoPediatrics, Lowers Price Target to $26
📈 PositiveBenzinga•Oct 29, 2025, 10:20 AM
BTIG Reiterates Buy on OrthoPediatrics, Maintains $23 Price Target
📈 PositiveBenzinga•Oct 29, 2025, 09:26 AM
OrthoPediatrics shares are trading higher following Q3 financial results.
📈 PositiveBenzinga•Oct 28, 2025, 08:09 PM
OrthoPediatrics Affirms FY2025 Sales Guidance of $233.500M-$234.500M vs $235.476M Est
➖ NeutralBenzinga•Oct 28, 2025, 08:08 PM
OrthoPediatrics Q3 Adj. EPS $(0.24) Beats $(0.26) Estimate, Sales $61.250M Miss $62.410M Estimate
➖ NeutralBenzinga•Oct 28, 2025, 08:07 PM
OrthoPediatrics Gets FDA's Approval For 3P Pediatric Plating Platform Small-Mini System
📈 PositiveBenzinga•Oct 28, 2025, 08:05 PM
Lake Street Maintains Buy on OrthoPediatrics, Lowers Price Target to $34
➖ NeutralBenzinga•Oct 10, 2025, 05:17 PM
Stifel Maintains Buy on OrthoPediatrics, Lowers Price Target to $20
➖ NeutralBenzinga•Oct 10, 2025, 01:49 PM•Also:
OrthoPediatrics shares are trading lower after the company issued Q3 sales guidance below estimates and cut its FY25 revenue guidance below estimates. Also, multiple firms lowered their respective price targets on the stock.
📉 NegativeBenzinga•Oct 10, 2025, 01:16 PM
JMP Securities Maintains Market Outperform on OrthoPediatrics, Lowers Price Target to $25
➖ NeutralBenzinga•Oct 10, 2025, 12:59 PM
Piper Sandler Maintains Overweight on OrthoPediatrics, Lowers Price Target to $22
➖ NeutralBenzinga•Oct 10, 2025, 12:35 PM
BTIG Maintains Buy on OrthoPediatrics, Lowers Price Target to $23
➖ NeutralBenzinga•Oct 10, 2025, 10:24 AM
OrthoPediatrics Lowers FY2025 Sales Guidance from $237.000M-$242.000M to $233.500M-$234.500M vs $239.440M Est
📉 NegativeBenzinga•Oct 9, 2025, 08:53 PM
OrthoPediatrics Sees Q3 Sales $61.200M vs $63.590M Est
📉 NegativeBenzinga•Oct 9, 2025, 08:53 PM
OrthoPediatrics Says In Q3, Faced Incremental Headwinds Late In Sept, Largely Due To Delayed 7d Capital Sales, Headwinds Within Latin, S. America Segment
📉 NegativeBenzinga•Oct 9, 2025, 08:24 PM
OrthoPediatrics Sees Q3 Revenue $61.2M Up 12%; Lowers FY2025 Guidance From $237M-$242M To $233.5M-$234.5M On 7D Capital Sales Uncertainty
➖ NeutralBenzinga•Oct 9, 2025, 08:19 PM
Frequently Asked Questions about KIDS
What is KIDS's current stock price?
OrthoPediatrics Corp. (KIDS) is currently trading at $17.07 per share. The stock has moved -2.85% today.
What is the analyst price target for KIDS?
The average analyst price target for KIDS is $24.00, based on 1 analyst.
What sector is OrthoPediatrics Corp. in?
OrthoPediatrics Corp. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is KIDS's market cap?
OrthoPediatrics Corp. has a market capitalization of $0.43 billion, making it a small-cap company.
Does KIDS pay dividends?
No, OrthoPediatrics Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBVS
Bioventus Inc.
$7.49
Mkt Cap: $0.5B
CBLL
CeriBell, Inc.
$21.20
Mkt Cap: $0.8B
EHAB
Enhabit, Inc.
$9.56
Mkt Cap: $0.5B
EOLS
Evolus, Inc.
$7.07
Mkt Cap: $0.5B
LAB
Standard BioTools Inc.
$1.63
Mkt Cap: $0.6B
RXST
RxSight, Inc.
$12.03
Mkt Cap: $0.5B
SMLR
Semler Scientific, Inc.
$17.93
Mkt Cap: $0.3B
SRDX
Surmodics, Inc.
$42.98
Mkt Cap: $0.6B
TMCI
Treace Medical Concepts, Inc.
$2.57
Mkt Cap: $0.2B
TOI
The Oncology Institute, Inc.
$3.50
Mkt Cap: $0.3B
Explore stocks similar to KIDS for comparison